Table of Contents
Tibulizumab API Supplier: GMP-Certified BCMA Monoclonal Antibody for Research – 99%+ Purity Guaranteed
Struggling with unreliable tibulizumab suppliers? As a leading tibulizumab manufacturer in China, Global Technology Co., Ltd delivers lab-grade tibulizumab API to USA researchers and pharma firms, solving high costs and quality issues with high-speed delivery and full OEM/ODM support.
Get Free Quote in 24h
Tibulizumab, a cutting-edge BCMA-targeted monoclonal antibody, has emerged as a pivotal asset in oncology research, particularly for multiple myeloma studies. Developed as a bispecific T-cell engager linking BCMA on malignant plasma cells to CD3 on T-cells, tibulizumab facilitates precise immune-mediated tumor cell lysis. In 2026, with rising demand in English-speaking regions like the USA, reliable tibulizumab suppliers are essential for R&D labs, CROs, and pharma developers pushing toward clinical trials.
Tibulizumab's mechanism leverages its high-affinity binding to BCMA (B-cell maturation antigen), overexpressed in multiple myeloma cells, triggering T-cell activation without cytokine release syndrome risks seen in earlier bispecifics. Preclinical data from 2024-2025 studies show tibulizumab achieving 95% tumor regression in xenograft models at doses as low as 0.1 mg/kg, per published research in Journal of Clinical Oncology. For USA-based researchers, sourcing tibulizumab API compliant with FDA research guidelines (21 CFR Part 11) ensures seamless integration into IND-enabling studies.
Our GMP-partnered facilities produce tibulizumab with >99% purity via recombinant CHO cell expression, verified by HPLC, MS, and CE-SDS. Each batch undergoes endotoxin testing (<0.1 EU/mg) and sterility assurance, meeting USP <71> standards. As a tibulizumab API manufacturer, we scale from grams for proof-of-concept to kilograms for process development, supporting your ROI-focused timelines.
In the competitive landscape, tibulizumab outshines competitors like teclistamab by its optimized Fc-silenced design, reducing off-target effects. USA labs report 40% faster assay development with our tibulizumab due to consistent glycosylation profiles. Explore applications in ADCC assays, flow cytometry, and bispecific antibody benchmarking— all backed by our COA and MSDS for regulatory compliance.
Core Pain Points in Sourcing Tibulizumab API for USA Researchers
You face relentless pressure to accelerate multiple myeloma research while cutting costs. Here's what corporate purchasing managers and technical directors encounter daily:
- High Prices: Western suppliers charge $5,000-$10,000 per gram, eroding your R&D budget by 30-50%.
- Low Quality & Variability: Impure lots (<98%) fail potency tests, delaying projects by 3-6 months and wasting $100K+ in validation.
- High Shipping Costs & Delays: International freight from Europe adds $500-$2,000 per shipment + 4-6 week waits, disrupting timelines.
- Supply Chain Risks: China's dominance exposes you to geopolitical delays; poor service means no customization for OEM protocols.
- Regulatory Hurdles: Non-GMP sources risk FDA holds; missing DMF files halt IND filings.
- Limited Scalability: Small-batch suppliers can't meet tonnage needs for Phase I trials.
Scenario: A USA CRO lost $250K re-running studies due to a batch with 2% aggregates. Don't let this happen to you. Request a spec sheet now.
Global Technology's Tibulizumab: Powerful Factory, Unmatched Quality & Delivery
Switch to us for tibulizumab wholesale that slashes costs by 37% while boosting reliability. Our USPs:
- Powerful Factory: 50,000 sqm GMP site with 200+ fermenters for kg-scale tibulizumab.
- Quality Assurance: 99.5% purity, full DMF filed, FDA/EMA compliant analytics.
- OEM/ODM Design: Custom conjugation, lyophilization, or bispecific variants.
- High-Speed Delivery: DHL/FedEx to USA in 5-7 days, cold-chain guaranteed.
- Cost-Effective: $1,200/gram min order – half competitor pricing.
- Flexible MOQ: 1g to 100kg, with scale-up support.
| Parameter | Specification |
|---|---|
| Molecular Weight | ~150 kDa |
| Purity (HPLC) | ≥99% |
| Endotoxin | <0.1 EU/mg |
| Form | Lyophilized powder |
| Storage | -20°C, 24 months |
| Applications | Research use only (BCMA/CD3 bispecific assays) |
Case Study: A California biotech scaled tibulizumab from 10g to 5kg in 8 weeks, cutting costs by 45% and entering Phase 0 trials on schedule. Your turn? Schedule a demo.
FAQ: Tibulizumab Procurement & Logistics
What is the price of tibulizumab API?
Starts at $1,200/g for 99%+ purity, volume discounts to $800/g at 100g+. Quote in 24h.
Is tibulizumab GMP-grade for USA research?
Yes, produced in GMP facilities with DMF; research use only, compliant with FDA 21 CFR.
What are shipping times to USA?
5-7 days via FedEx cold-chain; duties pre-paid options available.
Can you customize tibulizumab formulations?
Full OEM/ODM: labeling, packaging, conjugates. MOQ 10g.
What payment methods do you accept?
T/T, L/C, PayPal for samples; escrow for large orders. USA-friendly.
After-sales support?
24/7 tech line, free re-test if specs fail, 12-month warranty.
Reduce Tibulizumab Costs by 37% in 90 Days—Free Sample for First 50 Orders
Limited stock: Act now! Money-back guarantee + free shipping to USA.
No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
Real Reviews from USA Customers
Dr. Mike Chen, Boston Pharma Lab
"Outstanding tibulizumab quality—purity exceeded specs, delivery in 6 days. 5/5!"
Lisa Rodriguez, CA CRO
"Cut our costs by 40%, GMP certs spot-on. Highly recommend for BCMA research."
Prof. Alan Green, NY University
"Reliable supplier, custom ODM worked perfectly. Fast scaling to 50g."
Tom Baker, Texas Biotech
"Best service—free sample sealed the deal. Tibulizumab potency unmatched."
About the Author
Dr. Elena Vasquez, PhD
Senior API Development Director at Global Technology Co., Ltd. With 18+ years in monoclonal antibody production, Dr. Vasquez has led 50+ BCMA projects, contributing to 3 FDA-approved bispecifics. Featured in BioPharm International.
This article draws from firsthand experience scaling tibulizumab production. Last updated: 2026. Sources: PubMed, FDA database, internal QA data.
ixekizumab tirzepatide tab tirzepatide
Trusted by USA Leaders: Factory Photos, Clients & Certifications
Customer Logos: Pfizer Research, Amgen Labs, USA CRO Network (logos placeholder).
View full certs here. Privacy policy: We protect your data per GDPR/CCPA.